TCI Wealth Advisors Inc. purchased a new position in shares of Corteva, Inc. (NYSE:CTVA – Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 3,486 shares of the company’s stock, valued at approximately $205,000.
A number of other institutional investors also recently made changes to their positions in CTVA. Redmont Wealth Advisors LLC acquired a new position in shares of Corteva in the first quarter valued at approximately $25,000. Acadian Asset Management LLC acquired a new position in Corteva in the 1st quarter valued at $25,000. Albion Financial Group UT lifted its stake in shares of Corteva by 77.2% during the 1st quarter. Albion Financial Group UT now owns 505 shares of the company’s stock worth $29,000 after purchasing an additional 220 shares during the period. Capital Advisors Ltd. LLC boosted its holdings in shares of Corteva by 44.4% during the third quarter. Capital Advisors Ltd. LLC now owns 566 shares of the company’s stock worth $33,000 after purchasing an additional 174 shares during the last quarter. Finally, Cultivar Capital Inc. purchased a new stake in shares of Corteva in the second quarter valued at $34,000. 81.54% of the stock is owned by institutional investors and hedge funds.
Corteva Stock Up 1.3 %
NYSE CTVA opened at $61.13 on Tuesday. The company has a quick ratio of 1.17, a current ratio of 1.72 and a debt-to-equity ratio of 0.10. Corteva, Inc. has a fifty-two week low of $43.22 and a fifty-two week high of $61.25. The business has a 50 day moving average price of $57.27 and a two-hundred day moving average price of $55.19. The stock has a market cap of $42.61 billion, a PE ratio of 77.38, a P/E/G ratio of 1.66 and a beta of 0.77.
Analyst Upgrades and Downgrades
CTVA has been the topic of several recent analyst reports. Argus downgraded Corteva from a “buy” rating to a “hold” rating in a research report on Wednesday, August 7th. Morgan Stanley reissued an “overweight” rating and issued a $65.00 target price on shares of Corteva in a research report on Tuesday, September 24th. JPMorgan Chase & Co. lowered their target price on shares of Corteva from $57.00 to $55.00 and set a “neutral” rating for the company in a report on Friday, August 2nd. Wells Fargo & Company cut their price target on shares of Corteva from $67.00 to $65.00 and set an “overweight” rating on the stock in a research note on Friday, August 2nd. Finally, Bank of America raised shares of Corteva from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $59.00 to $67.00 in a research note on Wednesday, October 16th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $62.84.
Check Out Our Latest Report on Corteva
About Corteva
Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.
Further Reading
- Five stocks we like better than Corteva
- Which Wall Street Analysts are the Most Accurate?
- Inflation Risk Rising, Key Trades Investors Are Making Now
- Using the MarketBeat Stock Split Calculator
- 3 Oil Stocks to Watch Before Earnings Come Out
- The 3 Best Fintech Stocks to Buy Now
- Is American Express Stock’s Sell-the-News Reaction a Buying Opp?
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.